ArticleJournal of translational medicine2025

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.

Malin Hagberg Thulin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.